3[1]Pal Z,Dosa E,Pal A.Bacterial vaginosis and other vaginal infections.Int J Gynaecol Obstet,2005,89:278-279.
4[2]Ries AJ.Treatment of vaginal infections:candidiasis,bacterial vaginosis,and trichomoniasis.J Am Pharma Assoc,1997,NS37:563-569.
5[3]Polatti F,Nappi RE,Brundu B,et al.Clinical study on the dose-effect relationship of a Nifuratel-Nystatin combination in the treatment of vulvovaginal infections.Arzneim Forsch Drug Res,2003,53:730-737.
6[5]De-Seta F,Sartore A,Piccoli M.Bacterial vaginosis and preterm delivery:an open question.J Reprod Med,2005,50:313-318.
7[6]El-Din SS,Reynolds MT,Ashbee HR.Investigation into the pathogenesis of vulvo-vaginal candidosis.Sex Transm Infect,2001,77:179-183.
8[7]Parazzini F,Cintio E,Chianten V,et al.Determinants of different candida species infections of the genital tract in women,Sporachrom Study Group.Eur J Obstet Gynecol Reprod Biol,2002,93:141-145.
9[8]Mendling W,Poli A,Magnani P.Clinical effects of nifuratel in vulvovaginal infections.A meta-analysis of metronidazole -controlled trials.Arzneim Forsch Drug Res,2002,52:725-730.
10Mashburn J. Etiology, diagnosis, and management of vaginitis[J]. J Midwifery Womens Health, 2006, 51(6):423-430.
